An inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion for selective cancer therapy-Reference-Cited by-同舟云学术

An inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion for selective cancer therapy

Published:2019 Issue:29 Volume:10 Page:7068-7075
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Wu Ying¹²³⁴⁵,Guo Tao¹²³⁴⁵,Qiu Yuan¹²³⁴⁵,Lin Yan¹²³⁴⁵,Yao Yunyan¹²³⁴⁵,Lian Weibin⁶⁷⁸⁹¹⁰,Lin Lisen¹¹¹²¹³¹⁴,Song Jibin¹²³⁴⁵^ORCID,Yang Huanghao¹²³⁴⁵^ORCID

Affiliation:

1. MOE Key Laboratory for Analytical Science of Food Safety and Biology

2. State Key Laboratory of Photocatalysis on Energy and Environment

3. College of Chemistry

4. Fuzhou University

5. Fuzhou 350116

6. Department of Breast Surgery

7. Quanzhou First Hospital of Fujian

8. Medical University

9. Quanzhou 362000

10. P. R. China

11. National Institute of Neurological Disorders and Stroke (NINDS)

12. National Institutes of Health (NIH)

13. Bethesda

14. USA

Abstract

A kind of inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion, was developed for selective cancer therapy with high efficacy.

Funder

National Natural Science Foundation of China

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/SC/C9SC01070J

Reference44 articles.

1. Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2 -Based Nanoagent to Enhance Chemodynamic Therapy

2. Dye/Peroxalate Aggregated Nanoparticles with Enhanced and Tunable Chemiluminescence for Biomedical Imaging of Hydrogen Peroxide